EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Atara Biotherapeutics's enterprise value is $89.38 Mil.
Atara Biotherapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $8.57 Mil. Therefore, Atara Biotherapeutics's EV-to-Revenue for today is 10.43.
The historical rank and industry rank for Atara Biotherapeutics's EV-to-Revenue or its related term are showing as below:
ATRA'
s EV-to-Revenue Range Over the Past 10 Years
Min: -3.56 Med: 10.44 Max: 302
Current: 10.43
During the past 12 years, the highest EV-to-Revenue of Atara Biotherapeutics was 302.00. The lowest was -3.56. And the median was 10.44.
ATRA's EV-to-Revenue is ranked worse than 56.84% of 1031
companies
in the Biotechnology industry
Industry Median: 7.7
vs ATRA: 10.43
As of today (2024-04-23), Atara Biotherapeutics's stock price is $0.7099.
Atara Biotherapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.08. Therefore, Atara Biotherapeutics's PS Ratio for today is 8.87.
Atara Biotherapeutics EV-to-Revenue Historical Data
The historical data trend for Atara Biotherapeutics's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Atara Biotherapeutics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Atara Biotherapeutics EV-to-Revenue Distribution
For the Biotechnology industry and Healthcare sector, Atara Biotherapeutics's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Atara Biotherapeutics's EV-to-Revenue falls into.
Atara Biotherapeutics's current Enterprise Value is $89.38 Mil.
Atara Biotherapeutics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.57 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Atara Biotherapeutics's share price for today is $0.7099.
Atara Biotherapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.08.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Atara Biotherapeutics EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Atara Biotherapeutics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Atara Biotherapeutics (Atara Biotherapeutics) Business Description
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ATRA has been successfully added to your 